Tasked with developing and manufacturing effective therapeutics and vaccines for an ongoing global pandemic, the industry’s accomplishments have opened the door to next-generation technology.
However, a recent survey reveals gaps in pharma’s maintenance and reliability programs — and how they’re holding the industry back. Read the full findings in this research report.
This research report is sponsored by Augury